Inflammatory Breast Cancer
📧 Sign up to get email alerts when something new happens for Inflammatory Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer [Phase 2]
Phase 2 trial evaluating panitumumab with nab-paclitaxel and carboplatin for HER2-negative inflammatory breast cancer has completed recruitm…
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC) [Phase 2]
Phase 2 trial evaluating nivolumab in combination with chemotherapy as neoadjuvant treatment for inflammatory breast cancer has completed wi…
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC [Phase 2]
Phase 2 trial of bemcentinib plus pembrolizumab in triple-negative and inflammatory breast cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa [Phase 2]
A Phase 2 study evaluated paclitaxel plus trastuzumab and pertuzumab as pre-operative therapy for inflammatory breast cancer; the trial is c…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating whether maintenance chemotherapy after induction improves outcomes for inflammatory breast cancer; study c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Denosumab as an add-on Neoadjuvant Treatment (GeparX) [Phase 2]
Phase 2 trial update on denosumab added to neoadjuvant therapy for various breast cancer subtypes; study completed.
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy [Phase 3]
Phase 3 trial evaluating adjuvant chemotherapy in breast cancer patients who had partial or complete response to neoadjuvant chemotherapy.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update evaluating efficacy and tolerance of bevacizumab in Her2-negative inflammatory breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-07-17Clinical Trial Update: Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC) [Phase 2]
A Phase 2 trial of nintedanib for HER2-negative metastatic inflammatory breast cancer was terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer [Phase 2]
Phase 2 trial evaluating ipilimumab and nivolumab in recurrent stage IV HER2-negative inflammatory breast cancer; study terminated with resu…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: MUC1 Vaccine for Triple-negative Breast Cancer [EARLY_Phase 1]
An early-phase Phase 1 trial evaluating a MUC1 vaccine for breast cancer has completed its evaluation. The study targets inflammatory breast…
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer [Phase 2]
A Phase 2 study of Avastin (bevacizumab) in patients with inflammatory breast cancer or locally advanced breast cancer has completed, with r…
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of romidepsin plus Abraxane in HER2-negative inflammatory and metastatic breast cancer was terminated, with results posted…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial of bevacizumab for inflammatory breast cancer and locally advanced breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis
This completed NCI-sponsored clinical trial investigates tumor markers and factors associated with angiogenesis in inflammatory breast cance…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia
This entry reports the completion of a pilot clinical trial studying inflammatory breast cancer in Egypt and Tunisia.
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer [Phase 2]
A Phase 2 trial evaluating nab-paclitaxel with doxorubicin, cyclophosphamide, and pegfilgrastim, with or without bevacizumab, in women with …
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer [Phase 2]
A Phase 2 study evaluating lapatinib in combination with paclitaxel for newly diagnosed inflammatory breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy and peripheral blood stem cell transplant followed by Aldesleukin and Sargramostim in inflammatory Sta…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer [Phase 2]
Phase 2 trial evaluating a neoadjuvant regimen of sunitinib, paclitaxel, doxorubicin, and cyclophosphamide in stage IIB-IIIC breast cancer; …
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: TKI258 for Metastatic Inflammatory Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update for TKI258 in metastatic inflammatory breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer [Phase 2]
A Phase 2 trial evaluating adding cisplatin to neoadjuvant therapy for locally advanced breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer [Phase 2]
A Phase 2 trial of afatinib (BIBW2992) in HER2-overexpressing inflammatory breast cancer has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer. [Phase 2]
A Phase 2 study evaluating the combination of Avastin (bevacizumab) and trastuzumab (Herceptin) in patients with primary inflammatory HER2-p…
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating lapatinib in patients with relapsed or refractory inflammatory breast cancer has completed.